Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Upregulated CircRNAs With Efficacy in Preclinical <i>In Vivo</i> Models Reveal New Targets for Therapeutic Intervention in Glioma.

Cancer genomics & proteomics·2026
Same authorSame journal

Upregulated Circular RNAs in Gastric Cancer: Target Identification and Tools for Therapeutic Intervention.

Cancer genomics & proteomics·2026
Same author

Prostate Cancer: De-regulated Circular RNAs With Efficacy in Preclinical <i>In Vivo</i> Models.

Cancer genomics & proteomics·2025
Same author

CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention.

Cancer genomics & proteomics·2024
Same author

Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical <i>In Vivo</i> Models: Identification of Targets and New Modalities for Therapeutic Intervention.

Cancer genomics & proteomics·2024
Same author

Genome-wide classification of epigenetic activity reveals regions of enriched heritability in immune-related traits.

Cell genomics·2024

相关实验视频

Updated: Sep 9, 2025

Identification of Circular RNAs using RNA Sequencing
08:25

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

12.4K

膀癌:循环RNA在瘤发生,瘤抑制和治疗标识中的作用

Satu Nahkuri1, Ulrich H Weidle2

  • 1Roche Pharma Research and Early Development, Data & Analytics, Roche Innovation Center Zurich, Schlieren, Switzerland; satu.nahkuri@roche.com weidle49@t-online.de.

Cancer genomics & proteomics
|August 29, 2025
PubMed
概括
此摘要是机器生成的。

这项研究确定了循环RNAs (circRNAs) 作为膀癌 (BLC) 的潜在治疗点. 这些circRNA可以通过各种药物策略进行调节,为BLC提供新的治疗途径.

关键词:
基于抗体的药物复制疗法调节性RNA审查小分子抑制剂目标验证异种移植

更多相关视频

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.6K
Use of Alu Element Containing Minigenes to Analyze Circular RNAs
13:10

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

Published on: March 10, 2020

7.4K

相关实验视频

Last Updated: Sep 9, 2025

Identification of Circular RNAs using RNA Sequencing
08:25

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

12.4K
In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.6K
Use of Alu Element Containing Minigenes to Analyze Circular RNAs
13:10

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

Published on: March 10, 2020

7.4K

科学领域:

  • 癌症学
  • 分子生物学
  • 遗传学

背景情况:

  • 循环RNAs (circRNAs) 在癌症发病过程中起作用,作为瘤基因或瘤抑制剂.
  • 循环RNAs的失调与膀癌 (BLC) 的发展和进展有关.
  • 了解circRNA功能对于识别BLC中的新疗法目标至关重要.

研究的目的:

  • 在临床前BLC模型中识别介导疗效的circRNAs.
  • 根据它们在BLC病变发生中的功能作用对circRNA进行分类.
  • 探索针对BLC治疗的特定circRNA的治疗策略.

主要方法:

  • 在临床前BLC模型中搜索PubMed文献.
  • 按功能分类circRNAs (例如耐药性,信号传递,表观遗传修饰).
  • 对上调和下调循环RNA的治疗潜力的分析.

主要成果:

  • 已确定参与各种BLC病原机制的circRNA,包括药物耐药性和信号传递.
  • 循环RNA可以通过小分子,基于抗体的药物或核酸抑制剂进行调节.
  • 通过发现向纤维细胞生长因子受体的circRNA,被erdafitinib抑制来验证方法.

结论:

  • 在膀癌中,circRNA是有前途的治疗点.
  • 针对circRNAs为BLC提供了新的治疗方式,包括药物耐药性.
  • 埃尔达菲提尼布对向FGFR的circRNAs的疗效证实了这种治疗策略.